Clinical effects of non-pharmaceutical interventions for COVID-19 on other nationally notifiable infectious diseases in South Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: This study aimed to assess the impact of non-pharmaceutical interventions (NPIs) implemented during the COVID-19 pandemic on nationally notifiable infectious diseases (NNIDs) in South Korea. Methods: Long-term data on seven NNIDs from 2018 to 2021 were analyzed to identify trends and change points using a change point detection technique. The timings of the NPI implementations were compared to the identified change points to determine their association. Results: Varicella, mumps, and scarlet fever showed a significant decrease in incidence following the implementation of NPIs during the COVID-19 pandemic. These diseases, which are primarily transmitted through respiratory droplets, demonstrated a clear response to NPIs. However, carbapenem-resistant Enterobacterales (CRE) showed an increasing trend unrelated to the timing of NPI implementation, suggesting the complex nature of controlling healthcare-associated infections. Hepatitis A, hepatitis C, and scrub typhus did not show significant changes associated with NPIs, likely due to their non-respiratory route of transmission. Conclusions: NPIs effectively controlled NNIDs, particularly those transmitted through respiratory infections. However, the impact varied depending on the disease. Understanding the effectiveness and limitations of NPIs is crucial for developing comprehensive public health strategies during infectious disease outbreaks.
Abstract
Background/Aims: This study aimed to assess the impact of non-pharmaceutical interventions (NPIs) implemented during the COVID-19 pandemic on nationally notifiable infectious diseases (NNIDs) in South Korea. Methods: Long-term data on seven NNIDs from 2018 to 2021 were analyzed to identify trends and change points using a change point detection technique. The timings of the NPI implementations were compared to the identified change points to determine their association. Results: Varicella, mumps, and scarlet fever showed a significant decrease in incidence following the implementation of NPIs during the COVID-19 pandemic. These diseases, which are primarily transmitted through respiratory droplets, demonstrated a clear response to NPIs. However, carbapenem-resistant Enterobacterales (CRE) showed an increasing trend unrelated to the timing of NPI implementation, suggesting the complex nature of controlling healthcare-associated infections. Hepatitis A, hepatitis C, and scrub typhus did not show significant changes associated with NPIs, likely due to their non-respiratory route of transmission. Conclusions: NPIs effectively controlled NNIDs, particularly those transmitted through respiratory infections. However, the impact varied depending on the disease. Understanding the effectiveness and limitations of NPIs is crucial for developing comprehensive public health strategies during infectious disease outbreaks.
참고문헌 (27)
- "Severe acute respiratory syndrome (SARS), infection control" (2017)[URL]
- Bell D, "Non-pharmaceutical interventions for pandemic influenza, national and community measures", Emerg Infect Dis, 12, pp.88~94 (2006)
- Torner N, "Effectiveness of non-pharmaceutical measures in preventing pediatric influenza : a case-control study", BMC Public Health, 15, pp.543~ (2015)
- Gokmen Y, "Effects of non-pharmaceutical interventions against COVID-19 : a cross-country analysis", Int J Health Plann Manage, 36, pp.1178~1188 (2021)
- Sachs J, "Sustainable development report 2020" (2020), Cambridege Books
- Heymann DL, "COVID-19 : what is next for public health?", Lancet, 395, pp.542~545 (2020)
- Adegbija O, "Notifiable diseases after implementation of COVID-19public health prevention measures in Central Queensland, Australia", Commun Dis Intell (2018), pp.45~ (2021)
- Ullrich A, "Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany : an analysis of national surveillance data during week 1-2016-week 32-2020", Lancet Reg Health Eur, 6, pp.100103~ (2021)
- Lai CC, "The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan : a database analysis", Travel Med Infect Dis, 40, pp.101997~ (2021)
- Chen B, "Changes in incidence of notifiable infectious diseases in china under the prevention and control measures of COVID-19", Front Public Health, 9, pp.728768~ (2021)
- Geng MJ, "Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic", Nat Commun, 12, pp.6923~ (2021)
- "R: a language and environment for statistical computing" (2020)[URL]
- Geng Y, "Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China", J Infect, 84, pp.e13~e15 (2022)
- Kim DH, "Infectious respiratory diseases decreased during the COVID-19 pandemic in South Korea", Int J Environ Res Public Health, 18, pp.6008~ (2021)
- Tan HMJ, "The impact of COVID-19pandemic on the health-seeking behaviour of an Asian population with acute respiratory infections in a densely populated community", BMC Public Health, 21, pp.1196~ (2021)
- Sun X, "Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China", Hum Vaccin Immunother, 17, pp.4083~4089 (2021)
- Shah AP, "Seasonality of primarily childhood and young adult infectious diseases in the United States", Chronobiol Int, 23, pp.1065~1082 (2006)
- Sabale U, "Impact assessment of immunization and the COVID-19 pandemic on varicella across Europe using digital epidemiology methods : a descriptive study", PLoS One, 18, pp.e0283465~ (2023)
- O’Toole RF, "The interface between COVID-19 and bacterial healthcare-associated infections", Clin Microbiol Infect, 27, pp.1772~1776 (2021)
- Silva ARO, "Increased Use of antibiotics in the intensive care unit during coronavirus disease(COVID-19)pandemic in a Brazilian hospital", Front Pharmacol, 12, pp.778386~ (2021)
- Yamamoto N, "Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan", J Hosp Infect, 97, pp.212~217 (2017)
- "Hospital discharges and average length of stay" (2021)[URL]
- La Y, "Increase of multidrug-resistant bacteria after the COVID-19 pandemic in South Korea : time-series analyses of a long-term multicenter cohort", J Infect, 85, pp.702~769 (2022)
- Huh K, "Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019(COVID-19)outbreak in Korea : a nationwide surveillance study", Clin Infect Dis, 72, pp.e184~e191 (2021)
- Epidemiological investigation of infectious diseases in Republic of Korea, annual report 2019, "KDCA", KDCA, ~ (2021)
- Potasman I, "Infectious outbreaks associated with bivalve shellfish consumption : a worldwide perspective", Clin Infect Dis, 35, pp.921~928 (2002)
- Maheshwari A, "Acute hepatitis C", Lancet, 372, pp.321~332 (2008)